Patients with p16-positive oropharynx tumors were less likely to have viable tumors cells in salvage neck dissection samples (OR 0.09, 95%CI 0.02–0.44, P = 0.003). The gene discussed is CDKN2A; the disease is neoplasm of oropharynx.